299 related articles for article (PubMed ID: 31951003)
1. Neuropathology of Speech Network Distinguishes Bulbar From Nonbulbar Amyotrophic Lateral Sclerosis.
Shellikeri S; Keith J; Black SE; Zinman L; Yunusova Y
J Neuropathol Exp Neurol; 2020 Mar; 79(3):284-295. PubMed ID: 31951003
[TBL] [Abstract][Full Text] [Related]
2. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
[TBL] [Abstract][Full Text] [Related]
3. The neuropathological signature of bulbar-onset ALS: A systematic review.
Shellikeri S; Karthikeyan V; Martino R; Black SE; Zinman L; Keith J; Yunusova Y
Neurosci Biobehav Rev; 2017 Apr; 75():378-392. PubMed ID: 28163193
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes.
Takeuchi R; Tada M; Shiga A; Toyoshima Y; Konno T; Sato T; Nozaki H; Kato T; Horie M; Shimizu H; Takebayashi H; Onodera O; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol Commun; 2016 Jun; 4(1):61. PubMed ID: 27338935
[TBL] [Abstract][Full Text] [Related]
5. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
6. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
7. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
[TBL] [Abstract][Full Text] [Related]
8. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Takeda T
Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
[TBL] [Abstract][Full Text] [Related]
9. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
[TBL] [Abstract][Full Text] [Related]
10. Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset.
Kim HS; Son J; Lee D; Tsai J; Wang D; Chocron ES; Jeong S; Kittrell P; Murchison CF; Kennedy RE; Tobon A; Jackson CE; Pickering AM
BMC Neurol; 2022 Feb; 22(1):62. PubMed ID: 35189854
[TBL] [Abstract][Full Text] [Related]
11. Pathologic Involvement of Glutamatergic Striatal Inputs From the Cortices in TAR DNA-Binding Protein 43 kDa-Related Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis.
Riku Y; Watanabe H; Yoshida M; Mimuro M; Iwasaki Y; Masuda M; Ishigaki S; Katsuno M; Sobue G
J Neuropathol Exp Neurol; 2017 Sep; 76(9):759-768. PubMed ID: 28859339
[TBL] [Abstract][Full Text] [Related]
12. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
[TBL] [Abstract][Full Text] [Related]
13. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia.
Zhang H; Tan CF; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2008 Jan; 115(1):115-22. PubMed ID: 17786458
[TBL] [Abstract][Full Text] [Related]
14. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions.
Nishihira Y; Tan CF; Onodera O; Toyoshima Y; Yamada M; Morita T; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol; 2008 Aug; 116(2):169-82. PubMed ID: 18481073
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and pathological spectrum of TDP-43 associated ALS].
Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
[TBL] [Abstract][Full Text] [Related]
17. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S
Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065
[TBL] [Abstract][Full Text] [Related]
18. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis.
Geser F; Brandmeir NJ; Kwong LK; Martinez-Lage M; Elman L; McCluskey L; Xie SX; Lee VM; Trojanowski JQ
Arch Neurol; 2008 May; 65(5):636-41. PubMed ID: 18474740
[TBL] [Abstract][Full Text] [Related]
19. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.
Kawakami I; Arai T; Hasegawa M
Acta Neuropathol; 2019 Nov; 138(5):751-770. PubMed ID: 31555895
[TBL] [Abstract][Full Text] [Related]
20. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
